Ninth International Congress on Drug Therapy in HIV Infection
Glasgow, UK - 9-13 November 2008
|
Ninth International Congress on Drug Therapy in HIV InfectionGlasgow, UK - 9-13 November 2008 |
|
J Int AIDS Soc 2008, 11(Suppl 1):43 doi:10.1186/1758-2652-11-S1-O43
G Cairns1 and K Alcorn2
1 Community Representative, London, UK 2 NAM Publications, London, UK
Several international treatment guidelines now recommend that antiretroviral therapy should be initiated in all patients with a CD4 count below 350 cells/mm3. However, about 57% of UK patients are currently diagnosed with CD4 counts under 350, and 20% of patients currently with CD4 counts under this figure and diagnosed for longer than three months are not taking ARVs [1]. This plenary presentation will review the evidence for when to start therapy, look at CD4 counts at the start of therapy from European cohort studies, and analyse studies of patient opinion on ARV therapy and when to initiate it. It will also present information from an online survey of patients' knowledge and opinions on when to start therapy from the global HIV information website [http://www.aidsmap.com].
REFERENCE:
1. Chadborn T and Delpech V: What are the implications of increasing the recommended threshold for starting anti-HIV therapy (ART)? Fourteenth BHIVA Conference, Belfast 2008, Abstract O20.
2008-11-10
1758-2652-11-S1-O43
Copyright © 2008 Cairns et al; licensee BioMed Central Ltd
This information is designed to support, not replace, the relationship that exists between you and your doctor.
1980, 2009. AEGiS.